Kamada Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IL0010941198
ILS
25.69
0.21 (0.82%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

39.44 k

Shareholding (Dec 2025)

FII

10.00%

Held by 85 FIIs

DII

89.85%

Held by 1 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 9.54%

  • Poor long term growth as Net Sales has grown by an annual rate of 5.96% and Operating profit at 5.59% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
2

With ROE of 10.68%, it has a Expensive valuation with a 1.83 Price to Book Value

3

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

ILS 1,487 Million ()

stock-summary
P/E

17.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.03%

stock-summary
Debt Equity

-0.27

stock-summary
Return on Equity

9.02%

stock-summary
Price to Book

1.73

Revenue and Profits:
Net Sales:
145 Million
(Quarterly Results - Dec 2025)
Net Profit:
12 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
14.53%
0%
14.53%
6 Months
14.69%
0%
14.69%
1 Year
-1.31%
0%
-1.31%
2 Years
22.8%
0%
22.8%
3 Years
64.36%
0%
64.36%
4 Years
38.71%
0%
38.71%
5 Years
27.87%
0%
27.87%

Kamada Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
5.96%
EBIT Growth (5y)
5.59%
EBIT to Interest (avg)
22.03
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
0.64
Tax Ratio
7.96%
Dividend Payout Ratio
64.33%
Pledged Shares
0
Institutional Holding
13.52%
ROCE (avg)
9.54%
ROE (avg)
4.99%

Valuation key factors

Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
1.83
EV to EBIT
13.66
EV to EBITDA
8.88
EV to Capital Employed
2.13
EV to Sales
2.21
PEG Ratio
0.48
Dividend Yield
0.03%
ROCE (Latest)
15.63%
ROE (Latest)
10.68%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 1 Schemes (0.15%)

Foreign Institutions

Held by 85 Foreign Institutions (10.0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 0.62% vs 3.74% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -17.73% vs -26.94% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "145.30",
          "val2": "144.40",
          "chgp": "0.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "23.90",
          "val2": "36.20",
          "chgp": "-33.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "0.70",
          "chgp": "14.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "4.60",
          "val2": "-10.20",
          "chgp": "145.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "11.60",
          "val2": "14.10",
          "chgp": "-17.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "79.50%",
          "val2": "145.30%",
          "chgp": "-6.58%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 4.46% vs 13.36% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 30.28% vs 74.84% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "622.40",
          "val2": "595.80",
          "chgp": "4.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "141.90",
          "val2": "125.40",
          "chgp": "13.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.00",
          "val2": "2.40",
          "chgp": "25.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-9.60",
          "val2": "-30.40",
          "chgp": "68.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "69.70",
          "val2": "53.50",
          "chgp": "30.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "145.40%",
          "val2": "128.30%",
          "chgp": "1.71%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoYstock-summary

Dec'25
Dec'24
Change(%)
Net Sales
145.30
144.40
0.62%
Operating Profit (PBDIT) excl Other Income
23.90
36.20
-33.98%
Interest
0.80
0.70
14.29%
Exceptional Items
4.60
-10.20
145.10%
Consolidate Net Profit
11.60
14.10
-17.73%
Operating Profit Margin (Excl OI)
79.50%
145.30%
-6.58%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2025 is 0.62% vs 3.74% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is -17.73% vs -26.94% in Dec 2024

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
622.40
595.80
4.46%
Operating Profit (PBDIT) excl Other Income
141.90
125.40
13.16%
Interest
3.00
2.40
25.00%
Exceptional Items
-9.60
-30.40
68.42%
Consolidate Net Profit
69.70
53.50
30.28%
Operating Profit Margin (Excl OI)
145.40%
128.30%
1.71%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 4.46% vs 13.36% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 30.28% vs 74.84% in Dec 2024

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details